Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM · BSE: 507789 · Pharmaceuticals & Biotechnology · 45 announcements

Share price
₹235.40
Market cap
₹1,553 Cr
Revenue (annual)
₹287.2 Cr
Net profit (annual)
₹43.08 Cr
P/E (TTM)
34.1×Sector 47.3×
Promoter holding
69.05%+1.16% QoQ
FII holding
2.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:53 IST BSE
Employee Stock Options

Jagsonpal Pharmaceuticals Employee Stock Options

Jagsonpal Pharmaceuticals Limited allotted 27,950 equity shares following the exercise of employee stock options. This increases the company's total paid-up share capital to Rs. 13.19 Crore.

18:32 IST BSE
Employee Stock Options

Jagsonpal Pharmaceuticals Employee Stock Options

Jagsonpal Pharmaceuticals has granted 1,20,000 employee stock options under its 2022 ESOP plan. The options carry an exercise price of Rs. 179.25 each.

16:40 IST BSE
Employee Stock Options

Jagsonpal Pharmaceuticals Employee Stock Options

Jagsonpal Pharmaceuticals allotted 94,000 equity shares under its ESOP scheme. Consequently, the company's paid-up share capital increased to Rs. 13.18 Crore.

16:33 IST NSE
Employee Stock Options

Jagsonpal Pharmaceuticals Employee Stock Options

Jagsonpal Pharmaceuticals allotted 94,000 equity shares under its 2022 ESOP plan. This exercise increased the paid-up share capital to Rs. 13.19 Crore.

Value
₹0.89 Cr